the Beacon ® single B-cell platform, and a hybridoma development platform. Such platforms cover all processes, from antigen design and preparation to animal immunization, via antibody production ...

These host cells express the desired antibody that can be further purified and used for diverse applications. Recombinant antibody technology provides a wide range of benefits over traditional ...

Ipsen and Sutro Biopharma entered a global licensing deal for STRO-003, an ADC targeting ROR1, overexpressed in cancers, ...

Enhances B Cell Responses in Type 2 Inflammation Through IL-17RB Receptor,” published in the January 2025 issue of Allergy ...

The B-Body Platform simplifies bispecific antibody discovery by overcoming common production challenges ... transition from early discovery to cell line development and high-yield CMC, the ...

This article explores how broadly neutralizing antibodies are being researched, not only for their potential in the ...

No writing assistance was utilized in the production of this manuscript ... efficacy and between the agents themselves. Antibodies against B cells Rituximab is a depleting antibody directed ...

Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

Researchers at the Indian Institute of Science (IISc) have designed a synthetic compound (antigen) that can latch on to a protein in blood and hitchhike a ride to the lymph node, where it can ...